Patterns and predictors of chronic opioid use in older adults: A retrospective cohort study

GYeon Oh, Erin L Abner, David W Fardo, Patricia R Freeman, Daniela C Moga, GYeon Oh, Erin L Abner, David W Fardo, Patricia R Freeman, Daniela C Moga

Abstract

Background: Given the controversy around the effectiveness of opioid treatment for chronic pain and the lack of detailed guidance for prescribing opioids in older adults, the objectives of this study were to estimate the trajectories and predictors of opioid use in older adults.

Methods: Data were extracted from the National Alzheimer's Coordinating Center (2005-2017). Group-based trajectory modeling was used to identify the patterns of opioid use (any or strong) among participants age 65+. We used multivariable logistic regression with backward selection to evaluate demographics and comorbidities as potential predictors of trajectory membership.

Results: Among 13,059 participants, four trajectories were identified for the use of both any opioids and strong opioids (minimal-users, incident chronic-users, discontinuing-users, and prevalent chronic-users). For any opioids, female sex (adjusted odds ratio = 1.23; 95% confidence interval = 1.03-1.46), black vs. white (1.47; 1.18-1.82), year of education (0.96; 0.94-0.99), type of residence (independent group vs. private: 1.77; 1.38-2.26, care facility vs. private: 1.89; 1.20-2.97), hypertension (1.44; 1.20-1.72), cardiovascular disease (1.30; 1.09-1.55), urinary incontinence (1.45; 1.19-1.78), dementia (0.73; 0.57-0.92), number of medications (1 to 4 vs. none: 0.48; 0.36-0.64, 5 or more vs. none: 0.67; 0.50-0.88), and antidepressant agent (1.38; 1.14-1.67) were associated with incident chronic-use vs. non-use. For strong opioids, female sex (1.27; 1.04-1.56), type of residence (independent group vs. private: 1.90; 1.43-2.53, care facility vs. private: 2.37; 1.44-3.90), current smoking (1.68; 1.09-2.60), hypertension (1.49; 1.21-1.83), urinary incontinence (1.45; 1.14-1.84), dementia (0.73; 0.55-0.97), number of medications (1 to 4 vs. none: 0.46; 0.32-0.65, 5 or more vs. none: 0.59; 0.42-0.83), and antidepressant agent (1.55; 1.24-1.93) were associated with incident chronic-use vs. non-use.

Conclusion: Given that chronic opioid use was more prevalent in participants who were more vulnerable (i.e., older age, with multiple comorbidities, and polypharmacy), further studies should evaluate the safety and efficacy of using opioids in this population.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1. Sample selection flowchart.
Fig 1. Sample selection flowchart.
Fig 2. Estimated group-based trajectories for any…
Fig 2. Estimated group-based trajectories for any opioid and strong opioid use in National Alzheimer’s Coordinating Center (NACC) participants (2005–2017).

References

    1. Patel KV, Guralnik JM, Dansie EJ, Turk DC. Prevalence and impact of pain among older adults in the United States: findings from the 2011 National Health and Aging Trends Study. Pain. 2013;154(12):2649–57. 10.1016/j.pain.2013.07.029
    1. Wilder-Smith OH. Opioid use in the elderly. Eur J Pain. 2005;9(2):137–40. 10.1016/j.ejpain.2004.07.011
    1. Mantyselka P, Hartikainen S, Louhivuori-Laako K, Sulkava R. Effects of dementia on perceived daily pain in home-dwelling elderly people: a population-based study. Age Ageing. 2004;33(5):496–9. 10.1093/ageing/afh165
    1. Scherder E, Herr K, Pickering G, Gibson S, Benedetti F, Lautenbacher S. Pain in dementia. Pain. 2009;145(3):276–8. 10.1016/j.pain.2009.04.007
    1. Bell JS, Laitinen ML, Lavikainen P, Lonnroos E, Uosukainen H, Hartikainen S. Use of strong opioids among community-dwelling persons with and without Alzheimer's disease in Finland. Pain. 2011;152(3):543–7. 10.1016/j.pain.2010.11.003
    1. Chou R, Turner JA, Devine EB, Hansen RN, Sullivan SD, Blazina I, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015;162(4):276–86. 10.7326/M14-2559
    1. Krebs EE, Gravely A, Nugent S, Jensen AC, DeRonne B, Goldsmith ES, et al. Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial. JAMA. 2018;319(9):872–82. 10.1001/jama.2018.0899
    1. Mojtabai R. National trends in long-term use of prescription opioids. Pharmacoepidemiol Drug Saf. 2017.
    1. Miller M, Sturmer T, Azrael D, Levin R, Solomon DH. Opioid analgesics and the risk of fractures in older adults with arthritis. J Am Geriatr Soc. 2011;59(3):430–8. 10.1111/j.1532-5415.2011.03318.x
    1. Rolita L, Spegman A, Tang X, Cronstein BN. Greater number of narcotic analgesic prescriptions for osteoarthritis is associated with falls and fractures in elderly adults. J Am Geriatr Soc. 2013;61(3):335–40. 10.1111/jgs.12148
    1. Rudd RA, Seth P, David F, Scholl L. Increases in Drug and Opioid-Involved Overdose Deaths—United States, 2010–2015. MMWR Morb Mortal Wkly Rep. 2016;65(5051):1445–52.
    1. Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with the use of morphine and opiates. J Intern Med. 2006;260(1):76–87. 10.1111/j.1365-2796.2006.01667.x
    1. Kuo YF, Raji MA, Chen NW, Hasan H, Goodwin JS. Trends in Opioid Prescriptions Among Part D Medicare Recipients From 2007 to 2012. Am J Med. 2016;129(2):221 e21–30.
    1. Lalic S, Gisev N, Bell JS, Korhonen MJ, Ilomaki J. Predictors of persistent prescription opioid analgesic use among people without cancer in Australia. Br J Clin Pharmacol. 2018;84(6):1267–78. 10.1111/bcp.13556
    1. Thielke SM, Shortreed SM, Saunders K, Turner JA, LeResche L, Von Korff M. A Prospective Study of Predictors of Long-term Opioid Use Among Patients With Chronic Noncancer Pain. Clin J Pain. 2017;33(3):198–204. 10.1097/AJP.0000000000000409
    1. Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016. JAMA. 2016;315(15):1624–45. 10.1001/jama.2016.1464
    1. Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016. MMWR Recomm Rep. 2016;65(1):1–49. 10.15585/mmwr.rr6501e1
    1. Morris JC, Weintraub S, Chui HC, Cummings J, Decarli C, Ferris S, et al. The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord. 2006;20(4):210–6. 10.1097/01.wad.0000213865.09806.92
    1. Beekly DL, Ramos EM, Lee WW, Deitrich WD, Jacka ME, Wu J, et al. The National Alzheimer's Coordinating Center (NACC) database: the Uniform Data Set. Alzheimer Dis Assoc Disord. 2007;21(3):249–58. 10.1097/WAD.0b013e318142774e
    1. Beekly DL, Ramos EM, van Belle G, Deitrich W, Clark AD, Jacka ME, et al. The National Alzheimer's Coordinating Center (NACC) Database: an Alzheimer disease database. Alzheimer Dis Assoc Disord. 2004;18(4):270–7.
    1. Sutradhar R, Lokku A, Barbera L. Cancer survivorship and opioid prescribing rates: A population-based matched cohort study among individuals with and without a history of cancer. Cancer. 2017;123(21):4286–93. 10.1002/cncr.30839
    1. Pasero C, McCaffery M. Pain assessment and pharmacologic management St. Louis, MO: Mosby; 2010.
    1. Horgas AL, Snigurska U, Farland MZ, Marsiske M. Analyzing Analgesic Medications in Community-Dwelling Older Adults. Pain Med. 2018.
    1. Jones BL, Nagin DS, Roeder K. A SAS Procedure Based on Mixture Models for Estimating Developmental Trajectories. Sociological Methods & Research. 2001;29(3):374–93.
    1. Jones B, Nagin D. Advances in group-based trajectory modeling and an SAS procedure for estimating them. Sociological methods and research. 2007;35(4):542–71.
    1. Nagin D. Group-based modeling of development Cambridge, Mass.: Harvard University Press; 2005. x, 201 p. p.
    1. Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol. 2010;6:109–38. 10.1146/annurev.clinpsy.121208.131413
    1. Shield KD, Jones W, Rehm J, Fischer B. Use and nonmedical use of prescription opioid analgesics in the general population of Canada and correlations with dispensing levels in 2009. Pain Res Manag. 2013;18(2):69–74.
    1. Lalic S, Ilomaki J, Bell JS, Korhonen MJ, Gisev N. Prevalence and incidence of prescription opioid analgesic use in Australia. Br J Clin Pharmacol. 2018.
    1. Berecki-Gisolf J, Hassani-Mahmooei B, Clapperton A, McClure R. Prescription opioid dispensing and prescription opioid poisoning: Population data from Victoria, Australia 2006 to 2013. Aust N Z J Public Health. 2017;41(1):85–91. 10.1111/1753-6405.12568
    1. Hurley RW, Adams MC. Sex, gender, and pain: an overview of a complex field. Anesth Analg. 2008;107(1):309–17. 10.1213/01.ane.0b013e31816ba437
    1. Helme RD, Gibson SJ. The epidemiology of pain in elderly people. Clin Geriatr Med. 2001;17(3):417–31, v.
    1. Molton IR, Terrill AL. Overview of persistent pain in older adults. Am Psychol. 2014;69(2):197–207. 10.1037/a0035794
    1. Campbell CI, Weisner C, Leresche L, Ray GT, Saunders K, Sullivan MD, et al. Age and gender trends in long-term opioid analgesic use for noncancer pain. Am J Public Health. 2010;100(12):2541–7. 10.2105/AJPH.2009.180646
    1. Hunnicutt JN, Chrysanthopoulou SA, Ulbricht CM, Hume AL, Tjia J, Lapane KL. Prevalence of Long-Term Opioid Use in Long-Stay Nursing Home Residents. J Am Geriatr Soc. 2017.
    1. Jones CM, McAninch JK. Emergency Department Visits and Overdose Deaths From Combined Use of Opioids and Benzodiazepines. Am J Prev Med. 2015;49(4):493–501. 10.1016/j.amepre.2015.03.040
    1. Morrison RS, Siu AL. A comparison of pain and its treatment in advanced dementia and cognitively intact patients with hip fracture. J Pain Symptom Manage. 2000;19(4):240–8.
    1. McAuliffe L, Brown D, Fetherstonhaugh D. Pain and dementia: an overview of the literature. Int J Older People Nurs. 2012;7(3):219–26. 10.1111/j.1748-3743.2012.00331.x
    1. Kunik ME, Snow AL, Davila JA, Steele AB, Balasubramanyam V, Doody RS, et al. Causes of aggressive behavior in patients with dementia. J Clin Psychiatry. 2010;71(9):1145–52. 10.4088/JCP.08m04703oli
    1. Shega J, Emanuel L, Vargish L, Levine SK, Bursch H, Herr K, et al. Pain in persons with dementia: complex, common, and challenging. J Pain. 2007;8(5):373–8. 10.1016/j.jpain.2007.03.003
    1. Barnett ML, Olenski AR, Jena AB. Opioid-Prescribing Patterns of Emergency Physicians and Risk of Long-Term Use. N Engl J Med. 2017;376(7):663–73. 10.1056/NEJMsa1610524

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit